{"id":"https://openalex.org/W4283658313","doi":"https://doi.org/10.1111/dth.15667","title":"Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single\u2010center retrospective study in a real\u2010life setting","display_name":"Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single\u2010center retrospective study in a real\u2010life setting","publication_year":2022,"publication_date":"2022-06-28","ids":{"openalex":"https://openalex.org/W4283658313","doi":"https://doi.org/10.1111/dth.15667","pmid":"https://pubmed.ncbi.nlm.nih.gov/35762107","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9540270"},"language":"en","primary_location":{"id":"doi:10.1111/dth.15667","doi":"https://doi.org/10.1111/dth.15667","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dth.15667","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.15667","source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.15667","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015814702","display_name":"Matteo Megna","orcid":"https://orcid.org/0000-0003-1803-2046","observed_orcids":["https://orcid.org/0000-0003-1803-2046"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Matteo Megna","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0003-1803-2046","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054838950","display_name":"Luca Potestio","orcid":"https://orcid.org/0000-0001-5940-0592","observed_orcids":["https://orcid.org/0000-0001-5940-0592"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Potestio","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0001-5940-0592","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039155196","display_name":"Elisa Camela","orcid":"https://orcid.org/0000-0001-7201-9163","observed_orcids":["https://orcid.org/0000-0001-7201-9163"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisa Camela","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0001-7201-9163","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026402548","display_name":"Gabriella Fabbrocini","orcid":"https://orcid.org/0000-0002-0064-1874","observed_orcids":["https://orcid.org/0000-0002-0064-1874"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gabriella Fabbrocini","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0002-0064-1874","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025725407","display_name":"Angelo Ruggiero","orcid":"https://orcid.org/0000-0002-4658-7391","observed_orcids":["https://orcid.org/0000-0002-4658-7391"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angelo Ruggiero","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0002-4658-7391","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5015814702"],"corresponding_institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":4.4917,"has_fulltext":true,"cited_by_count":50,"citation_normalized_percentile":{"value":0.96477195,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"35","issue":"9","first_page":"e15667","last_page":"e15667"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":0.9779999852180481},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9070000052452087},{"id":"https://openalex.org/keywords/indirect-comparison","display_name":"indirect comparison","score":0.6880000233650208},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pasi-response","display_name":"PASI response","score":0.609000027179718},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6060000061988831},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","level":5,"score":0.9766491651535034},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9336953163146973},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6950947046279907},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.6335710287094116},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.46717485785484314},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.42652103304862976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3793063163757324},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.330791175365448},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.30440425872802734},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.30344751477241516}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/dth.15667","doi":"https://doi.org/10.1111/dth.15667","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dth.15667","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.15667","source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},{"id":"pmid:35762107","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35762107","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9540270","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9540270/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatol Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/dth.15667","doi":"https://doi.org/10.1111/dth.15667","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dth.15667","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.15667","source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283658313.pdf","grobid_xml":"https://content.openalex.org/works/W4283658313.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W1826301003","https://openalex.org/W1912289137","https://openalex.org/W2006249161","https://openalex.org/W2022917731","https://openalex.org/W2121126920","https://openalex.org/W2145834141","https://openalex.org/W2160247072","https://openalex.org/W2171889601","https://openalex.org/W2276035339","https://openalex.org/W2281847379","https://openalex.org/W2326643498","https://openalex.org/W2418506270","https://openalex.org/W2530333346","https://openalex.org/W2533556733","https://openalex.org/W2598622099","https://openalex.org/W2620306249","https://openalex.org/W2790122835","https://openalex.org/W2792548292","https://openalex.org/W2798169646","https://openalex.org/W2802931074","https://openalex.org/W2803625437","https://openalex.org/W2910616351","https://openalex.org/W2924895007","https://openalex.org/W2936242254","https://openalex.org/W2948260386","https://openalex.org/W2954022685","https://openalex.org/W2971152543","https://openalex.org/W2979742765","https://openalex.org/W2981616250","https://openalex.org/W2985580761","https://openalex.org/W2988907058","https://openalex.org/W2997875868","https://openalex.org/W3005854261","https://openalex.org/W3009701967","https://openalex.org/W3011730046","https://openalex.org/W3012894524","https://openalex.org/W3013229636","https://openalex.org/W3024843382","https://openalex.org/W3025936954","https://openalex.org/W3028355101","https://openalex.org/W3032261987","https://openalex.org/W3034210389","https://openalex.org/W3044878676","https://openalex.org/W3045278545","https://openalex.org/W3104634441","https://openalex.org/W3110279795","https://openalex.org/W3111570347","https://openalex.org/W3131268984","https://openalex.org/W3136709547","https://openalex.org/W3164716923","https://openalex.org/W3165928478","https://openalex.org/W3199565502","https://openalex.org/W3205535255","https://openalex.org/W3206039614","https://openalex.org/W3206711031","https://openalex.org/W3213569044","https://openalex.org/W4210391787","https://openalex.org/W4224224169","https://openalex.org/W4281288090"],"related_works":["https://openalex.org/W4382919080","https://openalex.org/W2783964106","https://openalex.org/W3011866593","https://openalex.org/W2990789745","https://openalex.org/W2113034544","https://openalex.org/W3044925367","https://openalex.org/W4309479473","https://openalex.org/W2765395943","https://openalex.org/W4377138261","https://openalex.org/W4213056883"],"abstract_inverted_index":{"Eleven":[0],"biologic":[1,54],"drugs":[2],"are":[3,11],"currently":[4],"approved":[5],"for":[6,99,131,196,211],"psoriasis":[7,40,100],"management.":[8],"Real-life":[9],"studies":[10],"needed":[12],"to":[13,28],"guide":[14],"clinicians":[15],"in":[16,39,109,182],"choosing":[17],"a":[18],"tailored-tail":[19],"therapy.":[20],"The":[21],"aim":[22],"of":[23,35,74,104,143,184,188],"our":[24],"retrospective":[25,45],"study":[26,46,205],"is":[27],"indirectly":[29],"compare":[30],"the":[31,70,110],"efficacy":[32,208],"and":[33,37,64,69,72,76,85,92,113,118,123,134,145,159,186,209,213],"safety":[34,73,210],"ixekizumab":[36,57,77,117,133,139,185,212],"brodalumab":[38,75,135,148,189,197],"patients.":[41],"A":[42,102],"single-centre":[43],"real-life":[44],"was":[47,194],"performed":[48],"enrolling":[49],"moderate-to-severe":[50],"psoriatic":[51],"patients":[52,106,115],"under":[53],"treatment":[55,78],"with":[56],"or":[58],"brodalumab.":[59,214],"For":[60],"each":[61,128],"patient,":[62],"clinical":[63],"demographic":[65],"data":[66],"were":[67,79,97,107,172,180],"collected":[68],"effectiveness":[71],"evaluated":[80],"at":[81,127,157,168],"weeks":[82],"4,":[83],"12,":[84],"24.":[86],"Psoriasis":[87],"Area":[88,95],"Severity":[89],"Index":[90],"(PASI)":[91],"Body":[93],"Surface":[94],"(BSA)":[96],"used":[98],"severity.":[101],"total":[103],"139":[105],"included":[108],"study:":[111],"98(70.5%)":[112],"41(29.5%)":[114],"received":[116],"brodalumab,":[119],"respectively.":[120,191],"Mean":[121],"PASI":[122],"BSA":[124],"significantly":[125],"reduced":[126],"follow":[129],"up":[130],"both":[132],"groups.":[136],"Even":[137],"if":[138],"reached":[140],"higher":[141,195],"rates":[142],"PASI90":[144],"PASI100":[146],"than":[147],"(PASI90:":[149],"43.8%":[150],"vs.":[151,155,162,166,199],"39.0%":[152],"PASI100:":[153,164],"20.4%":[154],"17.1%":[156],"week4":[158],"PASI90:":[160],"83.6%":[161],"75.6%":[163],"71.5%":[165],"60.9%":[167],"week24),":[169],"these":[170],"results":[171],"not":[173],"statistically":[174],"significant.":[175],"Adverse":[176],"events,":[177],"mainly":[178],"mild,":[179],"registered":[181],"25.5%":[183],"26.8%":[187],"group,":[190],"Discontinuation":[192],"rate":[193],"(17.1%":[198],"9.1%),":[200],"without":[201],"statistical":[202],"significance.":[203],"Our":[204],"showed":[206],"comparable":[207]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":23},{"year":2022,"cited_by_count":6}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2022-06-29T00:00:00"}